GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Valbiotis ALVAL.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.63

-2.03%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Valbiotis — daily ALVAL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Valbiotis on TradingView ↗
Market value
€14.9m
Last close × shares
Volume
56.7k
Shares, 9 Nov 2026

About Valbiotis

Its shares trade on Euronext Paris under the ticker ALVAL.PA. It has been listed since 7 June 2017. In the fiscal year to 31 December 2025, it reported revenue of €905,000 and a net loss of €9.4m. At that date it held total assets of €14.4m and shareholders' equity of €7.0m.

Valbiotis SA develops products and candidate drugs designed to prevent metabolic diseases. The company is headquartered in Perigny, Nouvelle-Aquitaine. The company went IPO on 2017-06-07. The firm specializes in developing nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. The company seeks to develop solutions designed to prevent type 2 diabetes, NASH, (non-alcoholic steatohepatitis) and obesity and to offer nutritional support. The firm prevents disease by developing products that reduce the risk factors of irreversible chronic diseases. The company provides patient support through new-generation medical nutrition solutions containing patented substances with clinically proven effects. Its products are plant-based and undergo strict scientific and clinical tests in collaboration with academic research centers.

Figures and description from our data supplier, not checked against the company's own report.

More about Valbiotis →

Latest on Valbiotis

Our reporting

We have not reported on Valbiotis yet.

Next results

17 Mar 2027

Due on 17 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Valbiotis's ticker?

Valbiotis trades as ALVAL.PA on Euronext Paris, under ISIN FR0013254851.

What was Valbiotis's last closing price?

0.63 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Valbiotis next report results?

Results are expected on 17 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.